The aim of the study was an evaluation of the effects of a 12-week physical training programme on the levels of bone turnover markers [Sclerostin, Osteocalcin (OC), C-terminal telopeptide of type I collagen (b-CTX)] in serum of women with osteopenia. Materials and methods: The study included 50 women at the age of 50-75 years with the diagnosis of osteopenia. During the initial 12 weeks (between point 1 and 2), the patients maintained their previous, normal level of physical activity. During subsequent 12 weeks (between point 2 and 3), a programme of exercise was implemented. The programme included the interval training on a bicycle ergometer, three times a week for 36 minutes. During the entire study duration, all the patients received a supplementation of calcium (500 mg) and vit. D 3 (1800 IU) once daily. Serum levels of OC, alkaline phosphatase (ALP), b-CTX and sclerostin were assayed at 3 time points. Results: After the course of the exercise cycle, the OC concentration was increased, sclerostin levels decreased, while no statistical differences were observed in b-CTX levels vs. the period of physical inactivity. No correlations were found between sclerostin level changes and osteocalcin level changes during the training time, probably because of too small groups. Neither statistically significant were the differences in alkaline phosphatase, calcium and phosphorus levels. 
Introduction
Mechanical loads, imposed on bones, induce the activation of osteocytes which make 90-95% of the cell component in adult skeleton [1, 2] . Osteocytes effectively identify mechanical signals, being located at small cavities, called lacunas, in the mineralised bone matrix. While transmitting signals to other cells, osteocytes initiate bone tissue rebuilding process [3, 4] . The mechanism, by which mechanical energy is transformed into electric stimuli, with subsequent biochemical responses, is called mechanotransduction and plays a key role in the process of skeleton adaptation to actual mechanical loads [5] .
Biochemical markers of bone turnover that reflect the cellular activity related to the bone formation and bone resorption can be useful in understanding the effects of physical activity on bone [6] . However, many of these markers demonstrate certain limitations, including the lack of specificity towards the osseous tissue, 
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an inability to identify metabolic activities of various bone elements. It should also be considered that these markers reflect mainly the function of osteoclasts and osteoblasts, and not the activity of osteocytes, while it is osteocytes which play the key role in maintaining skeleton integrity. Responding to these limitations, the latest studies on bone metabolism markers pay a special attention to sclerostin -the protein produced by osteocytes [7, 8] .
Sclerostin is being almost exclusively produced by osteocytes. It inhibits the transfer of signals towards activation, proliferation and differentiation of osteoblasts from mesenchymal cells. In case of bone lesions, osteocytes suppress sclerostin secretion in order to activate the processes of osteogenesis and bone repair [9] . Sclerostin overexpression in bone induces osteopenia [10] . Sclerostin stimulates the apoptosis of osteoblasts, thus providing a potential mechanism by which it may inhibit osteogenesis [10, 11] . A bone, which is not exposed to mechanical loads, faces the risk of sclerostin concentration increase and, in consequence, a higher incidence rate of osteocyte apoptosis, what enhances the recruitment of osteoclasts and thus bone resorption and loss processes [12] . Immobilisation and lack of physical activity may stimulate the synthesis of this protein [13] . Sclerostin is an inhibitor of the intracellular Wnt signalling pathway [9, 14] . The signalling via the Wnt pathway is a critical point for bone strength, as it stimulates the differentiation process of cells towards osteoblasts and bone tissue formation, while also suppressing resorption processes. Deactivation of sclerostin activity on the Wnt/b-catenin signalling pathway is tantamount to the anabolic effect and thus -to the prevalence of osteogenic mechanisms [9, 15] .
Osteocalcin (OC) is one of the markers of osteogenesis. OC is produced by mature osteoblasts, but some of circulating OC is released to circulation by osteoclasts [16] . OC concentration reflects the intensity of osteogenesis and is positively correlated with the histomorphometric parameters of the bone formation process [17] .
Physical activity imposes mechanical loads on bone tissue by the combined effect of external forces and muscular contractions which exert a higher impact on bones than other, gravitation-related forces [18] . However, some conditions are to be met in order to make physical conditions a source of positive effects for the bone system. The effectiveness of physical training in the prophylactics of osteoporosis depends, among others, on the intensity of physical exercises, the intervals between repetitions of the same exercise and of particular exercising sessions [19] . Thus a need emerges to design an appropriate training programme to be oriented onto the effective stimulation of osteogenic processes.
Study goals
The primary goal of the study was an evaluation of the effects of a 12-week interval training programme on sclerostin protein concentrations in serum, together with an assessment of the training influence on the concentration of bone metabolism markers: OC and C-terminal Telopeptide type 1 Collagen (b-CTX) in serum in female patients with low bone mass. Another (secondary) goal of the study was an evaluation of the relationships between sclerostin and OC concentrations and BMD.
Materials and methods
The study was carried out between January 2012 and December 2014. Physical activity trainings and blood collections were performed between September and April periods.
The participants included 50 female patients. Their age was varying between 50 and 75 years (see Table  I ). Inclusion criteria: female gender, clinical diagnosis -osteopenia (following the guidelines of the World Health Organisation for T-Score from -1.0 to -2.5 SD in proximal femur and/or lumbar spine densitometry); low or moderate physical activity, assessed by IPAQ -International Physical Activity Questionnaire [20] . Exclusion criteria: male gender; concomitant diseases (active inflammatory diseases, psychic diseases, impaired functionality of a motor organ, precluding any possibility to carry out a physiotherapy programme, BMD-affecting diseases); intake of bone metabolism affecting drugs, including, among others: bisphosphonates, strontium ranelate, glucocorticoids; disqualification by exercise test results.
The study lasted 24 weeks. During the first 12 weeks, the patients remained at the previous level of physical activity (between the 1st and the 2nd time point). During the other 12 weeks, a cardio workout programme was introduced (between the 2nd and the 3rd time point (see Figure 1) .
Before the study, all the patients were submitted to an exercise test at the Department of Sports Medicine. Out of the fifty qualified patients, the study project was completed by 41 women (82%). The causes of withdrawal included: motor organ pains during the exercise programme (n = 2), disease (n = 4), personal (n = 3). During the entire study duration, all the patients received a supplementation programme, including calcium (500 mg) and vit. D 3 (1800 IU) once daily.
Biochemical studies
Blood sampling was carried out fasting at 9:00 am to minimize circadian effects. Blood samples after the 12-weeks of interval physical training on a bicycle ergometer were collected next day after the last training session.
Biochemical assays, including bone turnover marker concentrations, employed the following methods and kits: -Alkaline Phosphatase -by the colorimetric method, supported by Olympus kits and analyser (of Olympus Life and Material Sciences, Ireland), at wave lengths of 410 and 480 nm, following the manufacturer's recommendations. -Osteocalcin (OC) and b-CrossLaps (b-CTX) by the electrochemiluminescence method, using an Elecsys 2010 analyser (Roche Diagnostics) and kits of Roche Diagnostics (Penzberg, Germany), following the manufacturer's recommendations. -Sclerostin by the ELISA Enzyme-Linked Immunosorbent Assay) with kits of Biomedica Gruppe (Vienna, Austria) and a Metertech e960 spectrophotometer (Metertech Inc., Taiwan). The assays were carried out at wavelengths of 450 nm, using a reference filter of 620 nm, following the instructions of the Elisa's manufacturer. The intra-and inter-assay coefficients of variation (CVs) were ≤ 7% and ≤ 10% and the limit of detection was 0.07 ng/ml. -Total calcium in serum -by quantitative colorimetric assay at wavelengths of 660 and 700 nm, using kits of Beckman Coulter (Beckman Coulter Inc., USA) and an Olympus analyser (Olympus Life and Material Sciences, Ireland), following the manufacturer's recommendations.
-Inorganic phosphorus content in serum, by the photometric method, at wavelengths of 340 and 380 nm, using kits and an analyser of Olympus (Olympus Life and Material Sciences, Ireland), according to the manufacturer's protocol. -Total vitamin D (25 hydroxyvitamin D3 and 25 hydroxyvitamin D2) by the electrochemiluminescence method, using an Elecsys 2010 analyser (Roche Diagnostics) and kits of Roche Diagnostics (Penzberg, Germany), following the manufacturer's recommendations. -The serum, used for sclerostin, b-CTX and OC assays, was frozen immediately after centrifuging and stored in temperature of -70°C until assayed. The other laboratory tests, i.e., serum calcium and phosphate levels, as well as the concentration of alkaline phosphatase, were measured on an ongoing basis in the morning and in fasting condition.
Densitometric examination
Bone mineral density studies were carried out by the dual-energy x-ray absorptiometry (DXA) method, using a GE Lunar Prodigy device. The minimum acceptable precision for technologists in our facility does not exceed the values: 1.9% (LSC = 5.3%) for Lumbar Spine, 1.8% (LSC = 5.0%) for Total Hip and 2% (LSC = 5.5%) for Femoral Neck.
Motor activity program
The biochemical tests were repeated after 12 weeks from the initial studies, using the same testing tools. Then, the patients, qualified to the programme, began the 12-week training of physical activity. It was an interval training, performed on a MONARK 915E testing bike ergometer. Training sessions were held three times a week. Each session lasted 36 minutes and consisted of 5 stages, preceded by a 4-minute warming-up (the total exercise time, including the warming-up, was 40 minutes). The training method was based on patient's 4-minute exercise, followed by a 2-minute rest phase. 
Statistical analysis
Distributions of variables at given time points and their conformity with normal distribution were examined in the first stage of analysis. The normality Shapiro-Wilk test was applied to verify the hypothesis of the normality of distributions of particular variables. In cases, where there were no grounds to refuse the hypothesis that a given distribution is conformable with the normal distribution, the ANOVA test was applied with repeated measurements. While in case of any incompatibility of distribution with the normal distribution, the Friedman ANOVA test was used (or the Wilcoxon pair sequence test in case when two points were compared).
Results

Results of physical activity level evaluation
All the patients were qualified on the basis of a questionnaire to a group, demonstrating a moderate level of physical activity. Based on the analysed data, significant differences were observed between vitamin D 3 concentrations before and after the study (see Table II ). Significantly higher values were obtained after the 12-week training on the testing bike ergometers vs. the values before the study (1 vs. 3) p < 0.001; 37.34% and before the onset of the 12-week interval training (2 vs. 3) p < 0.001; 26.8%.
Significant differences in Ca levels in serum were observed between time point (2) and time point (3). Prior to the 12-week physical training, Ca levels were significantly higher, when compared with the results after the 12-week training on the testing bike ergometers (2 vs. 3) p < 0.01; 3.23% (see Table II ).
Based on obtained data, statistically significantly higher serum OC concentrations were observed after the 12-week training period on the testing bike ergometers in comparison with OC concentration values before the study (1 vs. 3) p < 0.005; 9.09% and before the training (2 vs. 3) p < 0.001; 13.05% (see Figure 2) . A drop down of OC level was noted in six cases after training only.
No significant differences were obtained in b-CTX variable levels at the analysed time points (see Figure 3) .
Sclerostin concentrations were significantly lower after the 12-week physical training vs. its concentrations before the study (1 vs. 3) p < 0.001; by 12.04% and before the training on the testing bike ergometers (2 vs. 3) p < 0.001; by 12.44% (see Figure 4 ). An increase of sclerostin concentration was observed in four cases after training only. 
Correlations between absolute (differences) and relative changes
Because the distributions of absolute and relative differences (time points 1 and 3 and time points 2 and 3) for OC and sclerostin significantly differed from normal distribution (p < 0.05 for the Shapiro-Wilk test), the Spearman's rank correlation test was used for the analysis of the existing correlations. No significant correlations were observed during the performed study between the relative changes of osteocalcin concentrations at time points 1 and 3 and 2 and 3 and the corresponding absolute changes of sclerostin concentrations between time points 1 and 3 and 2 and 3, respectively (p > 0.05) (data not shown).
Discussion
Bone metabolic markers may be useful in the diagnosis and monitoring of not only osteoporosis [21, 22] , but may also be applied in other diseases that secondarily lead to bone metabolic disorders [23] [24] [25] . In our study we have assessed the effect of physical activity on changes in sclerostin and other known bone metabolism markers levels.
Significantly higher values of vitamin D 3 were obtained after the 12-week training on the testing bike ergometers vs. the values before the study (1 vs. 3; p < 0.001) and before the onset of the 12-week interval training (2 vs. 3; p < 0.001). All the patients were supplemented with calcium and vitamin D prior to enrollment and all of them declared good compliance in terms of above supplementation, but it is possible that the inclusion of the study led to its further improvement (greater involvement in the therapeutic process) and gradual increase of total serum vitamin D level.
Significantly lower serum Ca levels after training were probably associated with higher calcium utilization, as well as with changes in electrolyte concentrations and acid-base balance. The above changes depends on intensity of physical activity and load [26] .
Based on obtained data, statistically significantly higher serum OC concentrations were observed after the 12-week training period on the testing bike ergometers in comparison with OC concentration values before the study (p < 0.001). No significant differences were obtained in b-CTX variable levels at the analysed time points. In a study by Adami et al. [27] , similar results were obtained, concerning OC and b-CTX concentration changes after the physical activity programme in premenopausal women was over.
In a study by Pernambuco et al. [28] the influence of physical activity (aerobic in water) on BMD and serum 
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osteocalcin was evaluated, as well as the "stand up and go" test in 82 postmenopausal women with low BMD values. The patients were randomly divided into two groups: the water aerobic group -exercises twice a week during 8 months and a control group without regular exercises. After the study was over, a significant increase in serum OC levels was observed in the group of physically active patients, similarly as in our study. No statistically significant BMD differences were seen between the two groups.
There are relatively few studies about the effects of physical training on sclerostin levels [6] . Ardawi et al. [29] performed an evaluation of physical activity effects on sclerostin and bone turnover marker (BTM) levels in serum and on BMD. Women at the age of 20-49 years, were divided into two groups: one group undertaking physical activity (PA) > 120 minutes 4 times a week (n = 58) and a control group < 30 minutes of physical exercises a week (n = 62). An 8-week programme of physical activity, undertaken by the active group, provided decreases in serum sclerostin concentrations (by 33.9%, p = 0.0001) and increased serum levels of osteogenesis markers. The observed increased values of OC, ALP and procollagen type I N-terminal propeptide (PINP) were significantly higher in PA group. Thus, the authors of above study obtained convergent results to ours. Huovinen et al. [30] analyzed the effects of resistance training on the elderly patients with reduced muscle strength. After 16 weeks of intervention a significant increase in sclerostin and OC was noted, unlike the other markers (CTX and PINP).
Changes in bone markers levels may also be dependent on the primary BMD and kind of physical activity (discipline). In the study of Ahn et al. [31] after a 12-week exercise programme a significantly higher increase in OC concentration was seen in the group of female osteoporotic patients than in a group of women with normal BMD. Lombardi et al. [32] showed that intensive cycling is associated with a decrease in total OC serum concentrations and an increase in the percentage of its undercarboxylated fraction. The authors emphasized that the results were affected by a large individual variability. In another study [33] of 48 postmenopausal women with low BMD there were no differences in the concentrations of CTX and OC between the group of patients after a 10-week groupbased step aerobics and the control group. The different results were obtained by Mohr et al. [34] , who analyzed influence of 15 weeks of different forms of training on female population. In this study, a significant increase in bone resorption (CTX) and formation markers (OC and PINP) were obtained only in a subpopulation of women training football in comparison to the control group and swimming subpopulation, but before drawing the conclusions one should remember that these were premenopausal women. Study on a similar population of Polish women showed no difference between the concentrations of OC and CTX between the population of equestrians and the control group [35] .
Some clinical data suggest that circulating sclerostin is associated with BMD in older women and men. In one study [36] , a significant negative correlation was demonstrated between serum sclerostin and OC concentrations and BMD. By contrast, no correlation was observed in our study between sclerostin and OC concentration changes. It should be emphasised that the first 12 weeks in our study provided a control group for the later training cycle and the BMD evaluation was done for qualification at the moment, when the patients were included into the study, thus it is not possible to determine BMD changes. In several studies by other authors, higher BMD was demonstrated in groups of exercising women. Bergstrom et al. [37] analyzed BMD and BTM changes in a group of patients undertaking motor activity for 12 weeks (30-minute marches three times a week and one 1-hour aerobic training). After the training programme was over, a significant BMD increase was demonstrated in the femoral neck. CTX and ALP, bone turnover markers, revealed a slightly falling (insignificant) tendency in comparison to the control group.
A statistically significant BMD rise in the lumbar spine and in the neck was also achieved in a study of Gaudio et al. [38] after the physical activity. Additionally, a significant serum sclerostin increase was demonstrated in a group of immobilised postmenopausal female patients vs. a control group -physically active women -(p < 0.0001) -with higher bone turnover and prevalence of CTX vs. ALP. In the immobilised group, a negative correlations between sclerostin and ALP (r = -0.911; p < 0.0001) was observed and positive correlation with CTX (r = 0.391, p = 0.012). Those observations emphasise the important role of physical activity in bone formation processes [38] .
The literature reports on the sclerostin serum levels in athletes compared with non-active individuals are frequently inconclusive and call into question whether small differences in sclerostin levels are of physiologic or clinical significance. Gombos et al. [6] found that sclerostin levels increased in a similar group of women as in our study, who underwent a program of walking exercise or resistance exercise, compared to a control group. Similar results were presented by Zagrodna et al. [39] who reported that male athletes had significantly higher sclerostin levels than age-matched sedentary men. Also, Lombardi et al. [40] investigating sclerostin concentrations in elite athletes, found higher sclerostin levels in males participating in weight-bearing disciplines than in those who participated in nonweight-bearing sports. It can be assumed that different types of physical activity result in differences in sclerostin levels. Moreover, Lombardi et al. [40] , unlike to us, showed that individuals with low levels of physical activity have lower serum concentrations of sclerostin than professional rugby players or endurance athletes.
At present, the prophylactics of osteoporotic fractures is mainly based on pharmacotherapy which has proven effective in reducing fracture risks [41] . However, high doses of bisphosphonates, despite BMD improvement, may lead to accumulation of micro traumas and decreased ability to absorb energy by the trabecular bone, what may paradoxically lead to higher fracture risks [41] . Contrary to the therapy with medicinal agents, mechanical loads, achieved by properly targeted physical exercise, may lead to a considerable improvement of such properties as mechanical strength -i.e., the force level necessary to cause bone fracture. Still, physical exercises should never replace pharmacological therapy of osteoporosis, while -when properly planned -they improve a number of features and properties, regardless of BMD, including the sense of balance, gait mechanics, agility, muscular strength, resistance to fatigue, where none of the features depends on bisphosphonate therapy [41] .
One of the limitations in our study was the necessity to participate in each training session, 3 times a week for 12 weeks, which was unacceptable by some of our patients. We are also aware of the small size of our population. Our knowledge of the relationships between specific forms of physical effort and bone formation processes is rather limited. In the above described studies physical activity was evaluated in non-uniform ways and the studied populations differed significantly from each other. Based on reported study, an adopted programme of physical activity seems to be an effective way to stimulate osteogenesis processes in female patients with low bone mass.
Muscular contractions stimulate the formation processes of bones on their surface (periosteum), leading to an increased resistance to bending forces. It may then be more important than the BMD increase itself. Periosteal increase may falsify the actual effects on BMD, as it increases bone cross-section area, consequently increasing the denominator, used to calculate bone mineral density (i.e., bone mineral content/studied area). The example comes from studies on osteoporotic fractures [42] in which, women achieved higher body mass by increased bone strength, while reducing femoral bone BMD values. Therefore, the value of exercises in osteoporosis prophylactics and therapy cannot be fully evaluated by their effects on BMD [42] .
Summing up, the 12-week interval training on cycle ergometer bikes increased serum OC, while decreasing serum sclerostin concentrations. The bone turnover markers may be helpful in the evaluation of the efficacy of carried out physical activity, but we are aware that they have some limitations. OC plays also role in energy metabolism, e.g. physical activity (energy expenditure) and the changes of its concentrations could be partially independent of bone formation. Sclerostin concentration fall after properly planned physical training may play a significant function of osteoblastogenesis stimulator, and its serum concentrations may be considered as a potentially valuable parameter in the monitoring and forecasting of further therapy course, while strength training may be perceived as a multidirectional way of therapy in cases of osteopenia and postmenopausal osteoporosis.
Conclusions
The obtained results emphasise the role of physical activity as an effective stimulation method of bone formation processes in female patients with low bone mass, with many combined advantages for patient health. Sclerostin can be a marker of physical activity.
